Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 5/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.67 |
| ▸ | HTR2A | P28223 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | THPO | P40225 | 2/20 | 0.67 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.67 |
| ▸ | RGS12 | O14924 | 1/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxilofrine SCHEMBL14465574 | 1.00 | ADRA1A (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL14153976 | 1.00 | ADRA1A (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL147458 | 1.00 | ADRA1A (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL5173040 | 1.00 | ADRA1A (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL5174274 | 0.98 | KMT2A (0.68) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL29354826 | 0.98 | KMT2A (0.68) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| SCHEMBL23999268 | 0.83 | CYP2D6 (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| SCHEMBL20690347 | 0.83 | HIF1A (0.56) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| SCHEMBL23999280 | 0.83 | CYP2D6 (0.67) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR | |
| Oxilofrine SCHEMBL15347269 | 0.82 | TAAR1 (0.65) | ADRA1ACYP2D6CYP2C19CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042275-A1 | NOVEL PLASMIDS AND UTILIZATION THEREOF | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-1273665-B1 | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINO ALCOHOLS | DAIICHI FINE CHEM CO LTD (JP) | 2007-05-16 | — | — | EP | disclosed |
| US-6835559-B2 | Process for the production of optically active β-amino alcohols | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2004-12-28 | — | — | US | disclosed |
| US-20040091981-A1 | Process for the production of optically active beta-amino alcohols | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1273665-A1 | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINO ALCOHOLS | Daiichi Fine Chemical Co., Ltd. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042275-A1 | NOVEL PLASMIDS AND UTILIZATION THEREOF | COASY, BLVRB, TKT | ADRA1A 2061/4885CYP2D6 661/4885CYP2C19 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.